DSM and DSM-5 are trademarks of the American Psychiatric Association. The American Psychiatric Association is not affiliated with nor endorses this website.

Supporting Evidence

DSM-5 & American Psychiatric Association:

American Psychiatric Association (2011). DSM-5 Development. Retrieved from http://www.dsm5.org/Pages/Default.aspx

Kendler, K., Kupfer, D., Narrow, W., Phillips, K., & Fawcett, J. (2009, October 21). Guidelines for making changes to DSM-V. Retrieved August 30, 2011, from http://www.dsm5.org/ProgressReports/Documents/Guidelines-for-Making-Changes-to-DSM_1.pdf

Regier, D. A., Narrow, W. E., Kuhl, E. A., & Kupfer, D. J. (2011). The conceptual evolution of DSM-5. Arlington, VA: American Psychiatric Publishing.

Schatzberg, A. F., Scully, J. H., Kupfer, D. J., & Regier, D. A. (2009). Setting the record straight: A response to Frances commentary on DSM-V. Psychiatric Times, 26. Retrieved from http://www.psychiatrictimes.com/dsm/content/article/10168/1425806

British Psychological Society & American Counseling Association:

British Psychological Society. (2011) Response to the American Psychiatric Association: DSM-5 development. Retrieved from http://apps.bps.org.uk/_publicationfiles/consultationresponses/DSM-5%202011%20-%20BPS%20response.pdf

Frances, A. (2011b). Who needs DSM-5? A strong warning comes from professional counselors [Web log message]. Psychology Today. Retrieved from http://www.psychologytoday.com/blog/dsm5-in-distress/201106/who-needs-dsm-5

Lowering of diagnostic thresholds:

Compton, M. T. (2008). Advances in the early detection and prevention of schizophrenia. Medscape Psychiatry & Mental Health. Retrieved from http://www.medscape.org/viewarticle/575910

Frances, A. (2010). The first draft of DSM-V. BMJ. Retrieved from http://www.bmj.com/content/340/bmj.c1168.full

Frances, A. (2011a). DSM-5 approves new fad diagnosis for child psychiatry: Antipsychotic use likely to rise. Psychiatric Times. Retrieved from http://www.psychiatrictimes.com/display/article/10168/1912195

Andrews, G., & Hobbs, M. J. (2010). The effect of the draft DSM-5 criteria for GAD on prevalence and severity. Australia and New Zealand Journal of Psychiatry, 44, 784-790.

Hanssen, M., Bak, M., Bijl, R., Vollebergh, W., & van Os, J. (2005). The incidence and outcome of subclinical psychotic experiences in the general population. British Journal of Clinical Psychology, 44, 181-191.

Moran, M. (2009). DSM-V developers weigh adding psychosis risk. Psychiatric News Online. Retrieved from http://psychnews.psychiatryonline.org/newsarticle.aspx?articleid=112801

Other taxonomic issues:

Johns, L. C., & van Os, J. (2001). The continuity of psychotic experiences in the general population. Clinical Psychology Review, 21, 1125-1141.

Kendell, R., & Jablensky, A. (2003). Distinguishing between the validity and utility of psychiatric diagnoses. The American Journal of Psychiatry, 160, 4-11.

Livesley, W. J. (2010). Confusion and incoherence in the classification of Personality Disorder: Commentary on the preliminary proposals for DSM-5. Psychological Injury and Law, 3, 304-313.

Side-effects of psychotropic medications:

Ho, B-C., Andreasen, N. C., Ziebell, S., Pierson, R., & Magnotta, V. (2011). Long-term antipsychotic treatment and brain volumes. Archives of General Psychiatry, 68, 128-137.

Reynolds, G. P. (2010). Metabolic side effects of antipsychotic drug treatment – pharmacological mechanisms. Pharmacology & Therapeutics, 125, 169-179.

Roke, Y. van Harten, P. N., Boot, A. M., & Buitelaar, J. K. (2009). Antipsychotic medication in children and adolescents: A descriptive review of the effects on prolactin level and associated side effects. Journal of Child and Adolescent Psychopharmacology, 19, 403-414.

Rummel-Kluge, C., Komossa, K., Schwarz, S., Hunger, H., Schmid, F., Lobos, C. A., Kissling, W., & Davis, J. M. (2010). Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis. Schizophrenia Research, 123, 225-233.

Uchida, H. Kapur, S., Mulsant, B., Graff-Guerrero, A., Pollock, B. G., & Mamo, D. C. (2009). Sensitivity of older patients to antipsychotic motor side effects: A PET study examining potential mechanisms. American Journal of Geriatric Psychiatry, 17, 255-263.

Whitaker, R. (2002). Mad in America. Cambridge, MA: Basic Books. Also see http://www.madinamerica.com/madinamerica.co/Schizophrenia.html

Whitaker, R. (2010). Anatomy of an epidemic. New York, NY: Random House.

Please go to the petition website and sign the petition! Spread the word! Thank you!